{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:12:12Z","timestamp":1792390332696,"version":"4.4.0"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jconrel.2020.10.025","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T05:09:49Z","timestamp":1602824989000},"page":"895-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"special_numbering":"C","title":["Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery"],"prefix":"10.1016","volume":"328","author":[{"given":"Mahendra","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.10.025_bb0005","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0010","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systems--recent advances","volume":"17","author":"Bourlais","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0025","first-page":"60","article-title":"Mini drug pump for ophthalmic use","volume":"107","author":"Saati","year":"2009","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0030","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1111\/bph.14024","article-title":"Principles of pharmacology in the eye","volume":"174","author":"Awwad","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0035","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nano.2009.02.003","article-title":"Nanomedicines for ocular NSAIDs: safety on drug delivery","volume":"5","author":"Araujo","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/17425247.2016.1208649","article-title":"Advances in the use of prodrugs for drug delivery to the eye","volume":"14","author":"Taskar","year":"2017","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","article-title":"Advances and limitations of drug delivery systems formulated as eye drops","volume":"321","author":"Jumelle","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.addr.2017.09.008","article-title":"Overcoming ocular drug delivery barriers through the use of physical forces","volume":"126","author":"Huang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","article-title":"Nanotechnology in ocular drug delivery","volume":"13","author":"Sahoo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0060","doi-asserted-by":"crossref","first-page":"101400","DOI":"10.1016\/j.jddst.2019.101400","article-title":"Development of thermosensitive in situ gel nanoemulsions for ocular delivery of acyclovir","volume":"55","author":"Mahboobian","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0065","article-title":"Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis","volume":"124755","author":"Henostroza","year":"2020","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0070","doi-asserted-by":"crossref","first-page":"118979","DOI":"10.1016\/j.ijpharm.2019.118979","article-title":"Functional ibuprofen-loaded cationic nanoemulsion: development and optimization for dry eye disease treatment","volume":"576","author":"Dukovski","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13346-019-00697-0","article-title":"Design, optimisation and evaluation of in situ gelling nanoemulsion formulations of brinzolamide","volume":"10","author":"Bhalerao","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0080","doi-asserted-by":"crossref","first-page":"105229","DOI":"10.1016\/j.ejps.2020.105229","article-title":"Cationic nanoemulsions with prolonged retention time as promising carriers for ophthalmic delivery of tacrolimus","volume":"144","author":"Zhang","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2012.12.049","article-title":"Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits","volume":"443","author":"Tayel","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/604204","article-title":"Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb","volume":"2012","author":"Lallemand","year":"2012","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0095","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejps.2017.04.013","article-title":"Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide","volume":"104","author":"Morsi","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3109\/03639045.2012.707203","article-title":"Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing","volume":"39","author":"Pathak","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0105","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1080\/10717544.2016.1223225","article-title":"Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability","volume":"23","author":"Patel","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systems\u2014recent advances","volume":"17","author":"Le Bourlais","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00933-4","article-title":"rhEGF\/HP-\u03b2-CD complex in poloxamer gel for ophthalmic delivery","volume":"233","author":"Kim","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jphp.12075","article-title":"Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery","volume":"66","author":"Daull","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1208\/s12249-009-9268-4","article-title":"Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride","volume":"10","author":"Ammar","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0130","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C2SM06903B","article-title":"Nanoemulsions versus microemulsions: terminology, differences, and similarities","volume":"8","author":"McClements","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02569055","article-title":"The blood-ocular barriers: past, present, and future","volume":"93","author":"Cunha-Vaz","year":"1997","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0140","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/17425255.2010.486401","article-title":"The role of blood-ocular barrier transporters in retinal drug disposition: an overview","volume":"6","author":"Tomi","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/15569528709052169","article-title":"Selecting optimal dosage volumes for eye irritation tests in the rabbit","volume":"6","author":"Jacobs","year":"1987","journal-title":"Cut. Ocul. Toxicol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0168-3659(01)00279-6","article-title":"Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system","volume":"73","author":"Srividya","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.addr.2012.09.012","article-title":"Thermosensitive sol\u2013gel reversible hydrogels","volume":"64","author":"Jeong","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-3659(96)01523-4","article-title":"A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye","volume":"44","author":"Cohen","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jps.2600680606","article-title":"Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits","volume":"68","author":"Lee","year":"1979","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pharmaceutics10010028","article-title":"Ocular drug delivery barriers\u2014role of nanocarriers in the treatment of anterior segment ocular diseases","volume":"10","author":"Bachu","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0175","first-page":"39","article-title":"Ocular absorption following topical delivery","volume":"16","author":"Jtirvinena","year":"1995","journal-title":"Ad. Drug Del. Rev."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0180","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jps.2600650909","article-title":"Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes","volume":"65","author":"Patton","year":"1976","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0185","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2014.06.043","article-title":"Ocular delivery of macromolecules","volume":"190","author":"Kim","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0190","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0195","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/jps.2600721108","article-title":"Corneal penetration behavior of \u03b2-blocking agents I: physicochemical factors","volume":"72","author":"Schoenwald","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0200","first-page":"581","article-title":"The source of protein in the aqueous humor of the normal monkey eye","volume":"33","author":"Barsotti","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jps.2600660222","article-title":"Aqueous chamber drug distribution volume measurement in rabbits","volume":"66","author":"Conrad","year":"1977","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0210","series-title":"Ophthalmic Drug Delivery Systems","first-page":"156","article-title":"Ocular pharmacokinetics and pharmacodynamics","author":"Schoenwald","year":"2003"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14712598.3.1.45","article-title":"Drug delivery to the retina: challenges and opportunities","volume":"3","author":"Duvvuri","year":"2003","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1350-9462(99)00014-2","article-title":"Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery","volume":"19","author":"Bochot","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0225","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/17425247.2020.1735348","article-title":"Penetratin modified lutein nanoemulsion in-situ gel for the treatment of age-related macular degeneration","volume":"17","author":"Ge","year":"2020","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0230","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/pharmaceutics11090460","article-title":"Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents","volume":"11","author":"Souto","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0235","doi-asserted-by":"crossref","first-page":"101389","DOI":"10.1016\/j.jddst.2019.101389","article-title":"Target strategies for drug delivery bypassing ocular barriers","volume":"55","author":"Suri","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/1872213X12666180730115225","article-title":"Impact of ocular compatible lipoids and Castor oil in fabrication of brimonidine tartrate nanoemulsions by 33 full factorial design","volume":"12","author":"Newton","year":"2018","journal-title":"Recent Patents Inflamm. Allergy Drug Discov."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0245","series-title":"Nanoparticles for Biomedical Applications","first-page":"371","article-title":"Nanoemulsions","author":"Gupta","year":"2020"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0255","first-page":"202","article-title":"Experience with pilocarpine Ocuserts","volume":"97","author":"Hitchings","year":"1977","journal-title":"Trans. Ophthalmol. Soc. U. K."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0260","first-page":"55","article-title":"Pilocarpine-ocusert-p-40 in the handicapped glaucoma patient (author\u2019s transl)","volume":"167","author":"Krieglstein","year":"1975","journal-title":"Klin. Monatsbl. Augenheilkd."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0265","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1211\/0022357023691","article-title":"Nanosuspensions: a promising drug delivery strategy","volume":"56","author":"Patravale","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0270","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nano.2008.07.003","article-title":"Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application","volume":"5","author":"Agnihotri","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0275","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/20\/22\/225108","article-title":"Hybrid polymeric hydrogels for ocular drug delivery: nanoparticulate systems from copolymers of acrylic acid-functionalized chitosan and N-isopropylacrylamide or 2-hydroxyethyl methacrylate","volume":"20","author":"Barbu","year":"2009","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0280","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijbiomac.2008.12.009","article-title":"Photopolymerization of methacrylated chitosan\/PNIPAAm hybrid dual-sensitive hydrogels as carrier for drug delivery","volume":"44","author":"Han","year":"2009","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0285","series-title":"Ocular Ciprofloxacin Hydrochloride Mucoadhesive Chitosan-Coated Liposomes","author":"Abdelbary","year":"2009"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0290","first-page":"241","article-title":"Ciprofloxacin as ocular liposomal hydrogel","volume":"11","author":"Hosny","year":"2010","journal-title":"AAPS"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0295","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","article-title":"Nanotechnology in ocular drug delivery","volume":"13","author":"Sahoo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0300","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/10611860903079454","article-title":"Niosomes in sustained and targeted drug delivery: some recent advances","volume":"17","author":"Azeem","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0305","first-page":"466","article-title":"Discoidal niosome based controlled ocular delivery of timolol maleate","volume":"53","author":"Vyas","year":"1998","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0310","first-page":"467","article-title":"Solid lipid nanoparticles for ocular drug delivery","volume":"17","author":"Seyfoddin","year":"2010","journal-title":"Drug"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0315","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2174\/156720110791561008","article-title":"Development and evaluation of novel polymeric nanoparticles of brimonidine tartrate","volume":"7","author":"Singh","year":"2010","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0320","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.12.018","article-title":"Polymeric nanoparticulate system: a potential approach for ocular drug delivery","volume":"136","author":"Nagarwal","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0325","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1089\/jop.2007.0113","article-title":"Ocular gelling microspheres: in vitro precorneal retention time and drug permeation through reconstituted corneal epithelium","volume":"24","author":"Giannola","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0330","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0250-474X.41454","article-title":"Albumin microspheres as an ocular delivery system for pilocarpine nitrate","volume":"70","author":"Rathod","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0335","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejpb.2004.03.033","article-title":"The potential of lipid emulsion for ocular delivery of lipophilic drugs","volume":"58","author":"Tamilvanan","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2005.05.036","article-title":"Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate","volume":"301","author":"Yamaguchi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0345","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i1.30","article-title":"In situ gelling polymers in ocular drug delivery systems: a review","volume":"26","author":"Mundada","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0350","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10717540802689008","article-title":"Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers","volume":"16","author":"Al-Kassas","year":"2009","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clae.2007.09.002","article-title":"Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review","volume":"31","author":"Xinming","year":"2008","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0360","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1167\/iovs.03-0959","article-title":"Ophthalmic drug delivery through contact lenses","volume":"45","author":"Gulsen","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0365","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.biomaterials.2008.10.032","article-title":"Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs","volume":"30","author":"Kapoor","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0370","first-page":"214","article-title":"Development of an ophthalmic formulation containing ciprofloxacin-hydroxypropyl-b-cyclodextrin complex","volume":"142","author":"Nijhawan","year":"2003","journal-title":"Boll. Chim. Farm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0375","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/1567201043334623","article-title":"Role of cyclodextrins in ophthalmics","volume":"1","author":"Kaur","year":"2004","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0380","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejmech.2009.10.017","article-title":"Designing dendrimers for ocular drug delivery","volume":"45","author":"Spataro","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0385","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1248\/bpb.33.1371","article-title":"Effect of poly(amidoamine) dendrimers on corneal penetration of puerarin","volume":"33","author":"Yao","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0390","doi-asserted-by":"crossref","first-page":"R635","DOI":"10.1088\/0953-8984\/18\/41\/R01","article-title":"Nanoemulsions: formation, structure, and physical properties","volume":"18","author":"Mason","year":"2006","journal-title":"J. Phys. Condens. Matter"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0395","series-title":"Microemulsions: Properties and Applications","author":"Fanun","year":"2008"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0400","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/10611860903079454","article-title":"Niosomes in sustained and targeted drug delivery: some recent advances","volume":"17","author":"Azeem","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0405","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10717544.2010.483257","article-title":"Solid lipid nanoparticles for ocular drug delivery","volume":"17","author":"Seyfoddin","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0410","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0415","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0014-4835(78)90100-8","article-title":"Phospholipid effects on the rat lens transport systems","volume":"26","author":"Kador","year":"1978","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0420","first-page":"697","article-title":"Effects of lysophosphatidyl choline and phospholipase a on the lens","volume":"14","author":"Cotlier","year":"1975","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0425","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2005.11.020","article-title":"W\/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention","volume":"111","author":"Alany","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0430","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bjo.2004.051391","article-title":"Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease","volume":"89","author":"Aoki","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0435","article-title":"Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: improved pharmacokinetic\/pharmacodynamic properties","volume":"119402","author":"Ismail","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0440","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1039\/C5SM02958A","article-title":"Nanoemulsions: formation, properties and applications","volume":"12","author":"Gupta","year":"2016","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0445","first-page":"847","article-title":"Formulation development and evaluation of the therapeutic efficacy of brinzolamide containing nanoemulsions","volume":"16","author":"Mahboobian","year":"2017","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0450","doi-asserted-by":"crossref","first-page":"43","DOI":"10.31024\/apj.2018.3.2.2","article-title":"Nanoemulsion: a brief review on development and application in parenteral drug delivery","volume":"3","author":"Nikam","year":"2018","journal-title":"Adv. Pharm. J."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0455","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2017.11.049","article-title":"Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications","volume":"270","author":"Rai","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0460","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.foodhyd.2010.09.017","article-title":"Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle size","volume":"25","author":"Qian","year":"2011","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0465","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molliq.2015.11.050","article-title":"Critical steps and energetics involved in a successful development of a stable nanoemulsion","volume":"214","author":"Qadir","year":"2016","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0470","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4236\/jbnb.2011.225075","article-title":"Current state of nanoemulsions in drug delivery","volume":"2","author":"Lovelyn","year":"2011","journal-title":"J. Biomater. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0475","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/10942910600596464","article-title":"Nano-emulsion production by sonication and microfluidization-a comparison","volume":"9","author":"Jafari","year":"2006","journal-title":"Int. J. Food Prop."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0480","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2478\/acph-2019-0054","article-title":"In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery","volume":"69","author":"Dukovski","year":"2019","journal-title":"Acta Pharma."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0485","doi-asserted-by":"crossref","first-page":"100923","DOI":"10.1039\/C5RA17423F","article-title":"Quercetin delivery to porcine cornea and sclera by solid lipid nanoparticles and nanoemulsion","volume":"5","author":"Liu","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0490","first-page":"16","article-title":"Nanoemulsion formation by low-energy methods: a review","author":"Sokolov","year":"2014","journal-title":"\u0412\u0456\u0441\u043d\u0438\u043a \u0444\u0430\u0440\u043c\u0430\u0446\u0456\u0457"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0495","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1081\/DIS-200066829","article-title":"Physicochemical characterization of canola oil\/water nano-emulsions obtained by determination of required HLB number and emulsion phase inversion methods","volume":"27","author":"Moreira de Morais","year":"2006","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0500","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cocis.2012.07.003","article-title":"Nano-emulsions: formation by low-energy methods","volume":"17","author":"Solans","year":"2012","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0505","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3923\/ajdd.2012.143.183","article-title":"A review on novel therapeutic strategies for the enhancement of solubility for hydrophobic drugs through lipid and surfactant based self micro emulsifying drug delivery system: a novel approach","volume":"2","author":"Alexander","year":"2012","journal-title":"Am. J. Drug Disc. Dev."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0510","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2018.01.012","article-title":"Asymmetric flow field flow fractionation for the characterization of globule size distribution in complex formulations: a cyclosporine ophthalmic emulsion case","volume":"538","author":"Qu","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0515","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0378-5173(99)00086-1","article-title":"Physicochemical properties of chitosan-lipid emulsions and their stability during the autoclaving process","volume":"183","author":"Jumaa","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0520","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1097-4636(1999)48:2<111::AID-JBM3>3.0.CO;2-W","article-title":"Effects of dry heat and saturated steam on the physical properties of chitosan","volume":"48","author":"Lim","year":"1999","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0525","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2015.12.010","article-title":"Evaluation of the versatile character of a nanoemulsion formulation","volume":"498","author":"Gu\u00e9","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0530","first-page":"124","article-title":"Understanding emulsion eye drop technology","volume":"140","author":"Hom","year":"2003","journal-title":"Rev. Contact Lenses"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0535","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addr.2009.11.026","article-title":"Chitosan-based nanostructures: a delivery platform for ocular therapeutics","volume":"62","author":"de la Fuente","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0540","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/jop.2015.0054","article-title":"Comparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scraping","volume":"32","author":"Daull","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0545","first-page":"2","article-title":"Novasorb\u00ae cationic nanoemulsion and latanoprost: the ideal combination for glaucoma management","volume":"2","author":"Daull","year":"2017","journal-title":"Glauc. Open Access"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0550","first-page":"5053","article-title":"Mechanism of action of cationic emulsions in the management of ocular surface inflammation and wound healing","volume":"57","author":"Daull","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0555","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/ICO.0b013e31825e83f4","article-title":"Distribution of cyclosporine A in ocular tissues after topical administration of cyclosporine A cationic emulsions to pigmented rabbits","volume":"32","author":"Daull","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0560","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/jop.2011.0245","article-title":"A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models","volume":"28","author":"Daull","year":"2012","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0565","series-title":"Drug Delivery for the Retina and Posterior Segment Disease","first-page":"51","article-title":"Drug delivery to posterior segment of the eye: conventional delivery strategies, their barriers, and restrictions","author":"Yadav","year":"2018"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0570","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.addr.2008.09.002","article-title":"Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery","volume":"60","author":"Jiao","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0575","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/jop.2006.22.110","article-title":"Modulation of P-glycoprotein\u2013mediated efflux by prodrug derivatization: an approach involving peptide transporter\u2013mediated influx across rabbit cornea","volume":"22","author":"Katragadda","year":"2006","journal-title":"J. Ocul. Pharmacol. Therap."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0580","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2006.10.014","article-title":"Development and bioavailability assessment of ramipril nanoemulsion formulation","volume":"66","author":"Shafiq","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0585","article-title":"Preparation and evaluation of celecoxib nanoemulsion for ocular drug delivery","volume":"11","author":"Salimi","year":"2017","journal-title":"Asian J. Pharm. (AJP)"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0590","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.colsurfb.2016.08.048","article-title":"Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: formulation development, in-vitro and in-vivo studies","volume":"148","author":"Akhter","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0595","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2011.11.022","article-title":"Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and mice","volume":"160","author":"Hagigit","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0600","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/10837450.2018.1547748","article-title":"Brinzolamide\u2013loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests","volume":"24","author":"Mahboobian","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0605","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2012.10.015","article-title":"Development of O\/W nanoemulsions for ophthalmic administration of timolol","volume":"440","author":"Gallarate","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0610","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3109\/03639041003801885","article-title":"Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery","volume":"36","author":"Ammar","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0615","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/pharmaceutics11050230","article-title":"Nanoemulsion based vehicle for effective ocular delivery of moxifloxacin using experimental design and pharmacokinetic study in rabbits","volume":"11","author":"Shah","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0620","first-page":"327","article-title":"Mucoadhesive dexamethasone acetate-polymyxin B sulfate cationic ocular nanoemulsion\u2013novel combinatorial formulation concept","volume":"71","author":"M\u00fcller","year":"2016","journal-title":"Die Pharmazie-An Int. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0625","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1208\/s12249-016-0550-y","article-title":"Nanoemulsions containing a coumarin-rich extract from Pterocaulon balansae (Asteraceae) for the treatment of ocular Acanthamoeba keratitis","volume":"18","author":"Panatieri","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0630","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1023\/A:1020315228237","article-title":"Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine","volume":"19","author":"Basit","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0635","series-title":"Title 21, Code of Federal Regulations, Part 182, 184, 186. Office of the Federal Register, National Archives and Records Administration","author":"U.S. Food and Drug Administration","year":"2007"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0640","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1208\/pt0802028","article-title":"Formulation development and optimization using nanoemulsion technique: a technical note","volume":"8","author":"Shafiq-un-Nabi","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0645","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/10408398.2011.559558","article-title":"Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity","volume":"51","author":"McClements","year":"2011","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0650","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.foodhyd.2007.09.006","article-title":"Re-coalescence of emulsion droplets during high-energy emulsification","volume":"22","author":"Jafari","year":"2008","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0655","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/1541-4337.12189","article-title":"Formation of food-grade nanoemulsions using low-energy preparation methods: a review of available methods","volume":"15","author":"Komaiko","year":"2016","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0660","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1208\/s12249-014-0129-4","article-title":"Nanoemulsion for solubilization, stabilization, and in vitro release of pterostilbene for oral delivery","volume":"15","author":"Zhang","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0665","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1517\/17425247.2012.719870","article-title":"Potentials and challenges in self-nanoemulsifying drug delivery systems","volume":"9","author":"Khan","year":"2012","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0670","series-title":"Nanotechnology Applications in Food","first-page":"129","article-title":"Technological aspects of nanoemulsions and their applications in the food sector","author":"Saxena","year":"2017"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0675","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2009"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10915818509078685","article-title":"Final report on the safety assessment of stearyl alcohol, oleyl alcohol, and octyl dodecanol","volume":"4","author":"Elder","year":"1985","journal-title":"J. Am. Coll. Toxicol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0685","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.2042-7158.1996.tb03911.x","article-title":"Improved ocular bioavailability of indomethacin by novel ocular drug carriers","volume":"48","author":"Calvo","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0690","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(97)00369-4","article-title":"The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions","volume":"163","author":"Jumaa","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0695","first-page":"227","article-title":"Nanoemulsion as a novel ophthalmic delivery system for acetazolamide","volume":"6","author":"Morsi","year":"2014","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0700","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0705","first-page":"39","article-title":"Review on microemulsion as futuristic drug delivery","volume":"5","author":"Muzaffar","year":"2013","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0710","series-title":"Nanoemulsions","first-page":"207","article-title":"Fabrication of nanoemulsions by microfluidization","author":"Villalobos-Castillejos","year":"2018"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0715","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/js950474+","article-title":"Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers","volume":"85","author":"Calvo","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0720","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1016\/j.egypro.2019.01.650","article-title":"Effect of surfactant HLB value on methane hydrate formation in non-ionic surfactant-oil water emulsions systems","volume":"158","author":"Liu","year":"2019","journal-title":"Energy Procedia"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0725","first-page":"108","article-title":"HLB value, an important parameter for the development of essential oil phytopharmaceuticals","volume":"23","author":"Fernandes","year":"2013","journal-title":"Rev. Bras"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0730","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2004.05.016","article-title":"Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation","volume":"280","author":"Bouchemal","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0735","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1208\/s12249-008-9178-x","article-title":"Nanoemulsion components screening and selection: a technical note","volume":"10","author":"Azeem","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0740","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-3659(00)00325-4","article-title":"NMR characterisation and transdermal drug delivery potential of microemulsion systems","volume":"69","author":"Kreilgaard","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0745","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.msec.2019.04.069","article-title":"Thermo-responsive polymers: applications of smart materials in drug delivery and tissue engineering","volume":"102","author":"Sponchioni","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0750","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1755-3768.1975.tb00404.x","article-title":"Corneal temperature in normal subjects and arterial occlusive disease","volume":"53","author":"H\u00f8rven","year":"1975","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0755","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archopht.117.2.166","article-title":"Relationship between corneal temperature and finger temperature","volume":"117","author":"Girardin","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0760","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/17425247.2013.796360","article-title":"Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview","volume":"10","author":"Almeida","year":"2013","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0765","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/jfb6020277","article-title":"Nanomedicine approaches for corneal diseases","volume":"6","author":"Chaurasia","year":"2015","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0770","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.ijbiomac.2014.10.014","article-title":"Amphotericin-B entrapped lecithin\/chitosan nanoparticles for prolonged ocular application","volume":"72","author":"Chhonker","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0775","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/jbm.a.34467","article-title":"Part II: enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops","volume":"101","author":"Abul Kalam","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0780","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1542-0124(12)70028-9","article-title":"Tear osmolarity","volume":"4","author":"Murube","year":"2006","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0785","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/bm010008g","article-title":"Molecular basis of Ca2+\u2212induced gelation in alginates and pectins: the egg-box model revisited","volume":"2","author":"Braccini","year":"2001","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0790","first-page":"120","article-title":"Ion-sensitive nanoemulsion-in situ gel system for ophthalmic delivery of flurbiprofen axetil","volume":"45","author":"Shen","year":"2010","journal-title":"Yao xue xue bao Acta Pharm. Sin."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0795","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0753-3322(99)80088-2","article-title":"Prevention of topical and ocular oxidative stress by positively charged submicron emulsion","volume":"53","author":"Benita","year":"1999","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0800","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/OPTH.S75297","article-title":"An evaluation of Retaine\u2122 ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye","volume":"9","author":"Ousler","year":"2015","journal-title":"Clin. Ophthalmol. (Auckland, NZ)"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0805","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-5173(01)00980-2","article-title":"Development of novel topical tranexamic acid liposome formulations","volume":"235","author":"Manosroi","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0810","first-page":"427","article-title":"Ocular delivery of cyclosporin a. II. Effect of submicron emulsion\u2019s surface charge on ocular distribution of topical cyclosporin a","volume":"11","author":"Abdulrazik","year":"2001","journal-title":"STP Pharma Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0815","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jconrel.2010.04.013","article-title":"Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye","volume":"145","author":"Hagigit","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0820","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.colsurfb.2009.11.021","article-title":"Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe","volume":"76","author":"Bali","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0825","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0939-6411(02)00057-7","article-title":"Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability","volume":"54","author":"Jumaa","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0830","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10717540490280697","article-title":"Lipid nano\/submicron emulsions as vehicles for topical flurbiprofen delivery","volume":"11","author":"Fang","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0835","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/03639040802363704","article-title":"Formulation and characterization of nanoemulsion-based drug delivery system of risperidone","volume":"35","author":"Kumar","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0840","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1248\/cpb.56.1097","article-title":"Preparation and characterization of a new lipid nano-emulsion containing two cosurfactants, sodium palmitate for droplet size reduction and sucrose palmitate for stability enhancement","volume":"56","author":"Takegami","year":"2008","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0845","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2018.08.030","article-title":"Analytical considerations for measuring the globule size distribution of cyclosporine ophthalmic emulsions","volume":"550","author":"Petrochenko","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0850","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcis.2012.08.069","article-title":"Fabrication of vitamin E-enriched nanoemulsions: factors affecting particle size using spontaneous emulsification","volume":"391","author":"Saberi","year":"2013","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0855","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.carbpol.2008.09.002","article-title":"Fractionation and characterization of chitosan by analytical SEC and 1H NMR after semi-preparative SEC","volume":"75","author":"Nguyen","year":"2009","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0860","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejpb.2004.03.033","article-title":"The potential of lipid emulsion for ocular delivery of lipophilic drugs","volume":"58","author":"Tamilvanan","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0865","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.colsurfb.2008.11.034","article-title":"Comparative effects of different cosurfactants on sterile prednisolone acetate ocular submicron emulsions stability and release","volume":"69","author":"Ibrahim","year":"2009","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0870","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2010.04.029","article-title":"Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions","volume":"393","author":"Klang","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0875","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/ijms18071558","article-title":"Surface chemistry interactions of cationorm with films by human meibum and tear film compounds","volume":"18","author":"Georgiev","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0880","first-page":"32","article-title":"Development of topical nanoemulsions containing the isoflavone genistein","volume":"64","author":"Silva","year":"2009","journal-title":"Die Pharmazie-An Int. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0885","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00006324-199510000-00004","article-title":"Refractive index and osmolality of human tears","volume":"72","author":"Craig","year":"1995","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0890","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1442-9071.2004.00914.x","article-title":"New vehicle based on a microemulsion for topical ocular administration of dexamethasone","volume":"32","author":"Fialho","year":"2004","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0895","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/14786446408643645","article-title":"On the magnitude of a drop of liquid formed under different circumstances","volume":"27","author":"Tate","year":"1864","journal-title":"Lond. Edinburgh Dublin Philos. Magaz. J. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0900","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/2231-4040.85540","article-title":"Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment","volume":"2","author":"Kumar","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0905","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0002-9394(86)90771-3","article-title":"Drop size of commercial glaucoma medications","volume":"101","author":"Lederer","year":"1986","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0910","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0939-6411(97)00114-8","article-title":"The influence of penetration enhancers on the volume instilled of eye drops","volume":"45","author":"Van Santvliet","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0915","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/03639045.2016.1238924","article-title":"Tear fluid-eye drops compatibility assessment using surface tension","volume":"43","author":"Hotujac Grgurevi\u0107","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0920","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archopht.1969.00990020370014","article-title":"Measurement of the surface tension of tears","volume":"82","author":"Miller","year":"1969","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0925","first-page":"365","article-title":"Surface tension in tears","volume":"81","author":"De La L\u00e1grima","year":"2006","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0930","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0939-6411(96)00036-7","article-title":"Development and characterization of microemulsions for ocular application","volume":"43","author":"Ha\u03b2e","year":"1997","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0935","doi-asserted-by":"crossref","first-page":"12247","DOI":"10.1021\/la8019217","article-title":"Emulsification and stabilization mechanisms of O\/W emulsions in the presence of chitosan","volume":"24","author":"Payet","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0940","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2004.01.011","article-title":"Comparison of different ibuprofen-amino acid compounds with respect to emulsifying and cytotoxic properties","volume":"274","author":"Baydoun","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0945","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01062463","article-title":"Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye","volume":"20","author":"Rao","year":"1992","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0950","first-page":"465","article-title":"Microemulsions as potential ocular drug delivery systems: phase diagrams and physical properties depending on ingredients","volume":"62","author":"Radomska-Soukharev","year":"2005","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0955","first-page":"4641","article-title":"Effect of viscosity, surface tension and mucoadhesion on ocular residence time of lubricant eye drops","volume":"50","author":"Doshi","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0960","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clae.2017.11.004","article-title":"Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment","volume":"41","author":"Acar","year":"2018","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.jconrel.2020.10.025_bb0965","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jps.2600821102","article-title":"Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization","volume":"82","author":"Benita","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0970","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/02652040802211741","article-title":"Determination of entrapment efficiency and drug phase distribution of submicron emulsions loaded silybin","volume":"26","author":"Liu","year":"2009","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0975","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijpharm.2006.01.005","article-title":"Partitioning of parabens between phases of submicron emulsions stabilized with egg lecithin","volume":"312","author":"Watrobska-Swietlikowska","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0980","first-page":"455","article-title":"Ocular physiology and artificial tears","volume":"70","author":"L\u00f3pez-Alemany","year":"1999","journal-title":"J. Am. Optom. Assoc."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0985","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4103\/2231-4040.121416","article-title":"Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops","volume":"4","author":"Mohanty","year":"2013","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0990","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1444-0938.2011.00634.x","article-title":"Osmolality and tear film dynamics","volume":"95","author":"Stahl","year":"2012","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.jconrel.2020.10.025_bb0995","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1167\/iovs.05-1504","article-title":"Tear film osmolarity: determination of a referent for dry eye diagnosis","volume":"47","author":"Tomlinson","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1000","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archopht.1978.03910050076019","article-title":"Human tear osmotic pressure: diurnal variations and the closed eye","volume":"96","author":"Terry","year":"1978","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1005","first-page":"27","article-title":"Formulation of ophthalmic solutions and suspensions","author":"Van Ooteghem","year":"1993","journal-title":"Probl. Adv. Biopharm. Ocul. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1010","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1248\/bpb.32.1266","article-title":"Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid","volume":"32","author":"Yamaguchi","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/ejnm-2013-0012","article-title":"Ocular pharmacoscintigraphic and aqueous humoral drug availability of ganciclovir-loaded mucoadhesive nanoparticles in rabbits","volume":"5","author":"Akhter","year":"2013","journal-title":"Eur. J. Nanomed."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/02652048.2013.879930","article-title":"Prednisolone-loaded nanocapsules as ocular drug delivery system: development, in vitro drug release and eye toxicity","volume":"31","author":"Katzer","year":"2014","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/026119298901700106","article-title":"Vital dye release method for assessing the short-term cytotoxic effects of chemicals and formulations","volume":"17","author":"Reader","year":"1989","journal-title":"Altern. Lab. Anim"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1030","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/toxsci\/18.3.442","article-title":"Bovine corneal opacity and permeability test: an in vitro assay of ocular irritancy","volume":"18","author":"Gautheron","year":"1992","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1035","first-page":"271","article-title":"Trans-epithelial permeability of fluorescein in vitro as an assay to determine eye irritants","volume":"6","author":"Tchao","year":"1988","journal-title":"Altern. Methods Toxicol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/026119299001800117.1","article-title":"Loss of trans-epithelial impermeability of a confluent monolayer of Madin-Darby canine kidney (MDCK) cells as a determinant of ocular irritancy potential","volume":"18","author":"Shaw","year":"1990","journal-title":"Altern. Lab. Anim"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/faat.1995.1155","article-title":"Development and intralaboratory evaluation of an in vitro human cell-based test to aid ocular irritancy assessments","volume":"28","author":"Osborne","year":"1995","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1050","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0887-2333(95)00092-5","article-title":"The EC\/HO international validation study on alternatives to the Draize eye irritation test","volume":"9","author":"Balls","year":"1995","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.colsurfb.2010.07.029","article-title":"Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC","volume":"81","author":"Gonzalez-Mira","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1060","first-page":"525","article-title":"Validation of the red blood cell test system as in vitro assay for the rapid screening of irritation potential of surfactants","volume":"1","author":"Pape","year":"1987","journal-title":"Mol. Toxicol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1065","series-title":"In Vitro Toxicity Testing Protocols","first-page":"189","article-title":"The pollen tube growth test","author":"Kristen","year":"1995"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1070","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/10837450.2013.769569","article-title":"Castor oil and mineral oil nanoemulsion: development and compatibility with a soft contact lens","volume":"19","author":"Katzer","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-3659(02)00175-X","article-title":"Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies","volume":"83","author":"Wei","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1080","first-page":"377","article-title":"Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes","volume":"82","author":"Draize","year":"1944","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/026119291103900410","article-title":"In-house validation of the EpiOcularTM eye irritation test and its combination with the bovine corneal opacity and permeability test for the assessment of ocular irritation","volume":"39","author":"Kolle","year":"2011","journal-title":"Altern. Lab. Anim"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0278-6915(85)90030-4","article-title":"Hen\u2019s egg chorioallantoic membrane test for irritation potential","volume":"23","author":"Luepke","year":"1985","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s13346-015-0263-x","article-title":"Development and evaluation of ultra-small nanostructured lipid carriers: novel topical delivery system for athlete\u2019s foot","volume":"6","author":"Singh","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.05.023","article-title":"The hen\u2019s egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: quantification using Photoshop\u00ae and ImageJ","volume":"490","author":"McKenzie","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1211\/jpp.60.3.0004","article-title":"Cell culture models of the human cornea\u2014a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro","volume":"60","author":"Reichl","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/bjo.2003.028225","article-title":"Human corneal equivalent as cell culture model for in vitro drug permeation studies","volume":"88","author":"Reichl","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000143448","article-title":"Morphology and histochemistry of the corneal epithelium of mammals","volume":"75","author":"Ehlers","year":"1970","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0886-3350(01)01233-0","article-title":"Alkalinization increases penetration of lidocaine across the human cornea","volume":"28","author":"Fuchsj\u00e4ger-Mayrl","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1125","first-page":"335","article-title":"An in vitro model for determination of drug permeability through the cornea","volume":"22","author":"Camber","year":"1985","journal-title":"Acta Pharmaceutica Suecica"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2008.07.028","article-title":"Cyclosporine a loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity","volume":"364","author":"Gokce","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jps.2600760802","article-title":"Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea","volume":"76","author":"Ahmed","year":"1987","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/bjo.85.4.450","article-title":"A simple corneal perfusion chamber for drug penetration and toxicity studies","volume":"85","author":"Thiel","year":"2001","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1145","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2012.05.007","article-title":"Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes","volume":"47","author":"Loch","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0378-5173(02)00557-4","article-title":"Effect of iontophoresis on transcorneal permeation \u2018in vitro\u2019of two \u03b2-blocking agents, and on corneal hydration","volume":"250","author":"Monti","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.025_bb1160","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1248\/yakushi.126.1369","article-title":"Effect of formulation factors on in vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea","volume":"126","author":"Ahuja","year":"2006","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1165","series-title":"Nanoemulsion Eye Drop Composition Containing Cyclosporine and Method for Producing the Same","author":"Junyoubi","year":"2014"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1170","series-title":"Nanoemulsion form Ophthalmic, Composition","author":"Liang","year":"2011"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1175","series-title":"Translucent Oil-in-Water Nanoemulsion Useful for Preparing Cosmetic, Dermatological or Ophthalmological Compositions Comprises Three Specified Surfactant","author":"Quemin","year":"2001"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1180","series-title":"Ophthalmic Compositions and Methods of Use","author":"Arumugham","year":"2018"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1185","series-title":"Ophthalmic Composition Including High Sorbability Vitamin a-Including Nanoemulsion Particle and Method for Producing the Same","author":"Sasaki","year":"2012"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1190","series-title":"Ophthalmic Nano-Emulsion Composition Containing Cyclosporin for the Treatment of Dry-Eye-Syndrome","author":"Bokyung","year":"2010"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1195","series-title":"Micro- or Nano-Emulsion for Ophthalmic Use","author":"GmbH","year":"2014"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1200","series-title":"Non-irritant Ophthalmic Composition Containing Cyclosporin, and Convenient Preparation Method","author":"Dongwoo","year":"2018"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1205","series-title":"Cyclosporine-Containing Non-irritative Nanoemulsion Ophthalmic Composition","author":"Wang","year":"2016"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1210","series-title":"Ophthalmic Nanoemulsion Composition Containing Cyclosporine and Method for Preparing Same","author":"Lee","year":"2016"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1215","series-title":"Method for Regulating Retinal Endothelial Cell Viability","author":"Yates","year":"2018"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1220","series-title":"Method for Regulating Retinal Endothelial Cell Viability","author":"Yates","year":"2017"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1225","series-title":"WO2018233878A1","article-title":"An oil-in-water nanoemulsion composition of clobetasol","author":"Aquilue","year":"2019"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1230","series-title":"WO2020047197A1","article-title":"Ophthalmic compositions and methods of use","author":"Arumugham","year":"2020"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1235","series-title":"US10751337B2","article-title":"Preservative free ocular compositions and methods for using the same for treating dry eye disease and other eye disorders","author":"Jain","year":"2020"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1240","series-title":"A Ophthalmic Flurbiprofen Ester Nano-Emulsion In-Situ Gel Formulation and the Preparation Method Thereof, WO2010048788A1","author":"Li","year":"2010"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1245","series-title":"WO2010109482A2","article-title":"Curcuminoids and its metabolites for the application in allergic ocular\/nasal conditions","author":"Bhupathiraju","year":"2010"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1250","series-title":"KR101151235B1","article-title":"Ophthalmic composition in the form of nanoemulsion","author":"Lee","year":"2011"},{"key":"10.1016\/j.jconrel.2020.10.025_bb1255","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2147\/OPTH.S261318","article-title":"Efficacy and safety of phospholipid nanoemulsion-based ocular lubricant for the management of various subtypes of dry eye disease: a phase IV, multicenter trial","volume":"14","author":"Yeu","year":"2020","journal-title":"Clin. Ophthalmol. (Auckland, NZ)"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920306039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920306039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:23:38Z","timestamp":1718421818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920306039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":251,"alternative-id":["S0168365920306039"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.025","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}